BSX Boston Scientific Corporation | US1011371077
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 23.323.652.430 | 21.573.363.440 | 8.11% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 3,71 | 3,36 | 10.49% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 26 | 25 | 4.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |